BiochemProbe — Life Science Research Reagents

Ingliforib free base · Synonyms: CP 368296 | GPi 296

Ingliforib is a glycogen phosphorylase inhibitor.

For research use only. Not for human or veterinary use.

Target Phosphorylase
Research area Cardiovascular Disease
Purity >98% Stock Inquire

Ingliforib structure

CAS No.: 186392-65-4

Download structure (.mol)

Pack sizes & pricing

Size Price SKU Stock
50 mg USD 425.00 BP-01939-50mg In stock Get quote
100 mg USD 625.00 BP-01939-100mg In stock Get quote
250 mg USD 985.00 BP-01939-250mg In stock Get quote
500 mg USD 1,485.00 BP-01939-500mg In stock Get quote
1 g Inquire BP-01939-1g In stock Inquire

Need another size or custom synthesis? Request a quote.

Description

Ingliforib (CP 368296) is a glycogen phosphorylase inhibitor, with IC50s of 52, 352 and 150 nM for liver, muscle and brain glycogen phosphorylase, and has cardioprotective activity.

Biological activity

In Vitro Ingliforib is a glycogen phosphorylase inhibitor, and inhibits the myocardial GP isoforms (muscle and brain) with IC50s of 352 and 150 nM, respectively, also a potent inhibitor of the liver isoform (IC50 of 52 nM). Ingliforib (0.1, 1, 10 μM) dose-dependently reduces infarct size in the isolated rabbit hearts. In Vivo Ingliforib (15 mg/kg) potently reduces infarct size by 52%, and decreases plasma glucose and lactate concentrations in openchest anesthetized rabbits. Ingliforib (15 mg/kg) also inhibits myocardial glycogen phosphorylase a (GPa) and total glycogen phosphorylase (GP) activity in anesthetized rabbits.

Identifiers

SMILES
O=C(C(N1)=CC2=C1C=CC(Cl)=C2)N[C@@H](CC3=CC=CC=C3)[C@@H](O)C(N4C[C@@H](O)[C@@H](O)C4)=O
InChIKey
GVDRRZOORHCTAN-MJUUVYJYSA-N

Specifications

MW (average)
457.9070
Formula
C23H24ClN3O5
CAS No.
186392-65-4
Physical state
Solid
Color
light yellow to yellow
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage
Powder -20℃ 2 years; In solvent -20℃ 1 month;

Solubility

Soluble in DMSO

References

[1]. Tracey WR, et al. Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor. Am J Physiol Heart Circ Physiol. 2004 Mar;286(3):H1177-84.

Same research area

Search Cardiovascular Disease